AZD9567 is primarily investigated for its potential therapeutic applications in the treatment of inflammatory diseases. It is being studied as a selective glucocorticoid receptor modulator, aiming to provide anti-inflammatory benefits while minimizing the side effects commonly associated with traditional glucocorticoid therapies. This makes it a promising candidate for managing conditions such as rheumatoid arthritis, asthma, and other chronic inflammatory disorders. Its development focuses on improving patient outcomes by offering a safer and more targeted approach to inflammation control.